{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:48:31Z","timestamp":1792460911211,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-6795-0","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T14:03:06Z","timestamp":1557324186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"Luiza Helena Falleiros","family":"Arlant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Catalina Pirez","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Avila Aguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cashat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia Irene","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara J.","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"6795_CR1","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.","journal-title":"Nat Rev Dis Primers"},{"key":"6795_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365\u201376.","journal-title":"Lancet."},{"key":"6795_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ncl.2008.03.011","volume":"26","author":"NH Mueller","year":"2008","unstructured":"Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008;26:675\u201397 viii.","journal-title":"Neurol Clin"},{"key":"6795_CR4","first-page":"265","volume":"89","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89:265\u201388.","journal-title":"Wkly Epidemiol Rec"},{"key":"6795_CR5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1046\/j.1365-3156.1998.00316.x","volume":"3","author":"BW Lee","year":"1998","unstructured":"Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Tropical Med Int Health. 1998;3:886\u201390.","journal-title":"Tropical Med Int Health"},{"key":"6795_CR6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/tmi.12040","volume":"18","author":"C Masuet-Aumatell","year":"2013","unstructured":"Masuet-Aumatell C, Ramon-Torrell JM, Casanova-Rituerto A, Banque-Navarro M, Davalos-Gamboa Mdel R, Montano-Rodriguez SL. Seroprevalence of varicella-zoster virus infection in children from Cochabamba: tropical or temperate pattern? Tropical Med Int Health. 2013;18:296\u2013302.","journal-title":"Tropical Med Int Health"},{"key":"6795_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1046\/j.1365-3156.2002.00852.x","volume":"7","author":"A Bartoloni","year":"2002","unstructured":"Bartoloni A, Bartalesi F, Roselli M, et al. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, South-Eastern Bolivia. Tropical Med Int Health. 2002;7:512\u20137.","journal-title":"Tropical Med Int Health"},{"key":"6795_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4269\/ajtmh.2001.64.131","volume":"64","author":"S Lolekha","year":"2001","unstructured":"Lolekha S, Tanthiphabha W, Sornchai P, et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg. 2001;64:131\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"6795_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1017\/S0950268800050019","volume":"108","author":"GP Garnett","year":"1992","unstructured":"Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect. 1992;108:513\u201328.","journal-title":"Epidemiol Infect"},{"key":"6795_CR10","first-page":"175","volume":"17","author":"ML Avila-Aguero","year":"2018","unstructured":"Avila-Aguero ML, Beltran S, Castillo JBD, et al. Varicella epidemiology in Latin America and the Caribbean. Expert Rev Vaccines. 2018;17:175\u201383.","journal-title":"Expert Rev Vaccines."},{"key":"6795_CR11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/INF.0b013e31826ff3a5","volume":"31","author":"A Bardach","year":"2012","unstructured":"Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean--a systematic review and meta-analysis. Pediatr Infect Dis J. 2012;31:1263\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"6795_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","volume":"16","author":"P Wutzler","year":"2017","unstructured":"Wutzler P, Bonanni P, Burgess M, Gershon A, Safadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16:833\u201343.","journal-title":"Expert Rev Vaccines."},{"key":"6795_CR13","doi-asserted-by":"publisher","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","volume":"137","author":"M Marin","year":"2016","unstructured":"Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137:e20153741.","journal-title":"Pediatrics."},{"key":"6795_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1542\/peds.2010-3385","volume":"128","author":"M Marin","year":"2011","unstructured":"Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128:214\u201320.","journal-title":"Pediatrics."},{"key":"6795_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/adc.2007.126243","volume":"93","author":"J Quian","year":"2008","unstructured":"Quian J, Ruttimann R, Romero C, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child. 2008;93:845\u201350.","journal-title":"Arch Dis Child"},{"key":"6795_CR16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/INF.0b013e318260cc4d","volume":"31","author":"B Tan","year":"2012","unstructured":"Tan B, Bettinger J, McConnell A, et al. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008. Pediatr Infect Dis J. 2012;31:956\u201363.","journal-title":"Pediatr Infect Dis J"},{"key":"6795_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jama.294.7.797","volume":"294","author":"F Zhou","year":"2005","unstructured":"Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005;294:797\u2013802.","journal-title":"JAMA."},{"key":"6795_CR18","unstructured":"Deseda C, for the Varicella Task Force. Prevenci\u00f3n de varicela en Am\u00e9rica Latina y el Caribe. Documento de Posici\u00f3n de la SLIPE https:\/\/www.the-ahf.org\/sites\/default\/files\/FINAL%20-%20Varicella%20Position%20Paper%20June%2020%202016.pdf . Accessed 26 Nov 2018."},{"key":"6795_CR19","unstructured":"Parellada CI, Perez Carrega ME, Massoc MA, et al. A perspective on the introduction of publica varicela vaccination in Latin America and Caribbean. Presented at: SLIPE 2017 - XVII Congreso Latinoamericano de Infectolog\u00eda Pedi\u00e1trica; November 8-11, 2017; Cancun, Mexico."},{"key":"6795_CR20","unstructured":"Domingues CMAS, de Oliveira Garcia MH, Minist\u00e9rio da Sa\u00fade Bras\u00edlia. Mudan\u00e7as no Calend\u00e1rio Nacional de Vacina\u00e7\u00e3o para o ano de 2018 (Brazil, 2018 public immunization schedule). http:\/\/www.smp.org.br\/arquivos\/site\/protocolo-meningite-5-edicao-completo-3-2.pdf . Accessed 26 Nov 2018."},{"key":"6795_CR21","unstructured":"Peru 2018 Public immunization schedule. Norma t\u00e9cnica de salud que establece el esquema nacional de vacunaci\u00f3n. http:\/\/busquedas.elperuano.pe\/download\/url\/modifican-la-norma-tecnica-de-salud-que-establece-el-esquem-resolucion-ministerial-n-068-2018minsa-1613632-3 . Accessed 26 Nov 2018."},{"key":"6795_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/14760584.2017.1247700","volume":"16","author":"ML Avila-Aguero","year":"2017","unstructured":"Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-Trejos A. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination. Expert Rev Vaccines. 2017;16:229\u201334.","journal-title":"Expert Rev Vaccines"},{"key":"6795_CR23","first-page":"300","volume":"84","author":"G Giachetto","year":"2013","unstructured":"Giachetto G. Varicela: situaci\u00f3n epidemiol\u00f3gica y actualizaci\u00f3n de las medidas de prevenci\u00f3n. Arch Pediatr Urug. 2013;84:300\u20132.","journal-title":"Arch Pediatr Urug"},{"key":"6795_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1\u201334.","journal-title":"J Clin Epidemiol"},{"key":"6795_CR25","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1128\/JCM.42.12.5698-5704.2004","volume":"42","author":"GH Dayan","year":"2004","unstructured":"Dayan GH, Panero MS, Debbag R, et al. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol. 2004;42:5698\u2013704.","journal-title":"J Clin Microbiol"},{"key":"6795_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/13696998.2018.1431919","volume":"21","author":"N Giglio","year":"2018","unstructured":"Giglio N, Monsanto H, Rampakakis E, Yang HK, Kuter BJ, Wolfson LJ. Economic burden of varicella in children 1-12 years of age in Argentina, 2009-2014. J Med Econ. 2018;21:416\u201324.","journal-title":"J Med Econ"},{"key":"6795_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/S0036-46652005000300004","volume":"47","author":"MM Lafer","year":"2005","unstructured":"Lafer MM, de Moraes-Pinto MI, Weckx LY. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination. Rev Inst Med Trop Sao Paulo. 2005;47:139\u201342.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"6795_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajic.2007.04.283","volume":"36","author":"AM dos Santos","year":"2008","unstructured":"dos Santos AM, Ono E, Lobato RT, et al. Diphtheria, tetanus, and varicella immunity in health care workers in neonatal units. Am J Infect Control. 2008;36:142\u20137.","journal-title":"Am J Infect Control"},{"key":"6795_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1365-4362.2003.01310.x","volume":"42","author":"I Semenovitch","year":"2003","unstructured":"Semenovitch I, Lupi O. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil. Int J Dermatol. 2003;42:193\u20136.","journal-title":"Int J Dermatol"},{"key":"6795_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1590\/S0021-75572009000400016","volume":"85","author":"E Kupek","year":"2009","unstructured":"Kupek E, Tritany EF. Impact of vaccination against varicella on the reduction of the disease incidence in children and adolescents from Florianopolis, Brazil. J Pediatr. 2009;85:365\u20138.","journal-title":"J Pediatr"},{"key":"6795_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/S1807-59322006000200010","volume":"61","author":"R Marcitelli","year":"2006","unstructured":"Marcitelli R, Bricks LF. Varicella zoster in children attending day care centers. Clinics (Sao Paulo). 2006;61:147\u201352.","journal-title":"Clinics (Sao Paulo)"},{"key":"6795_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1590\/S1415-790X2009000400002","volume":"12","author":"KS dos Anjos","year":"2009","unstructured":"dos Anjos KS, Ferreira MME, Arruda MC, Ramos KS, Magalh\u00e3es APR. Caracteriza\u00e7\u00e3o epidemiol\u00f3gica dos casos de varicela em pacientes internados em um hospital universit\u00e1rio da cidade do Recife. Revista Brasileira de Epidemiologia. 2009;12:523\u201332.","journal-title":"Revista Brasileira de Epidemiologia"},{"key":"6795_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jped.2015.10.003","volume":"92","author":"A de Martino Mota","year":"2016","unstructured":"de Martino Mota A, Carvalho-Costa FA. Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine. J Pediatr. 2016;92:361\u20136.","journal-title":"J Pediatr"},{"key":"6795_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ajic.2009.04.283","volume":"37","author":"MI Dinelli","year":"2009","unstructured":"Dinelli MI, Moreira T, Paulino ER, da Rocha MC, Graciani FB, de Moraes-Pinto MI. Immune status and risk perception of acquisition of vaccine preventable diseases among health care workers. Am J Infect Control. 2009;37:858\u201360.","journal-title":"Am J Infect Control"},{"key":"6795_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1590\/S0036-46652000000300002","volume":"42","author":"AL Yu","year":"2000","unstructured":"Yu AL, Costa JM, Amaku M, et al. Three year seroepidemiological study of varicella-zoster virus in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2000;42:125\u20138.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"6795_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/S0950268801006124","volume":"127","author":"AL Yu","year":"2001","unstructured":"Yu AL, Amaku M, Burattini MN, Massad E, Azevedo RS. Varicella transmission in two samples of children with different social behaviour in the state of Sao Paulo, Brazil. Epidemiol Infect. 2001;127:493\u2013500.","journal-title":"Epidemiol Infect"},{"key":"6795_CR37","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/S0924-8579(13)70537-5","volume":"42","author":"OM Le\u00f3n-Casta\u00f1eda","year":"2013","unstructured":"Le\u00f3n-Casta\u00f1eda OM, Ramirez-Ramirez MM, Medina-Cordoba A, Rodriguez-Morales AJ. P296 epidemiological trends of varicella in a western department of Colombia, 2008-2012. Int J Antimicrob Agents. 2013;42:S135\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"6795_CR38","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1590\/S0102-311X2011000700014","volume":"27","author":"AJ Idrovo","year":"2011","unstructured":"Idrovo AJ, Albavera-Hernandez C, Rodriguez-Hernandez JM. Social epidemiology of a large outbreak of chickenpox in the Colombian sugar cane producer region: a set theory-based analysis. Cad Saude Publica. 2011;27:1393\u2013402.","journal-title":"Cad Saude Publica"},{"key":"6795_CR39","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1016\/j.vaccine.2013.08.077","volume":"31","author":"C Conde-Glez","year":"2013","unstructured":"Conde-Glez C, Lazcano-Ponce E, Rojas R, et al. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine. 2013;31:5067\u201374.","journal-title":"Vaccine."},{"key":"6795_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0188-0128(98)00006-2","volume":"30","author":"MT Alvarez y Munoz","year":"1999","unstructured":"Alvarez y Munoz MT, Torres J, Damasio-Santana L, et al. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. Arch Med Res. 1999;30:60\u20133.","journal-title":"Arch Med Res"},{"key":"6795_CR41","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1006\/pmed.2001.0825","volume":"32","author":"MA Villasis-Keever","year":"2001","unstructured":"Villasis-Keever MA, Pena LA, Miranda-Novales G, et al. Prevalence of serological markers against measles, rubella, varicella, hepatitis B, hepatitis C, and human immunodeficiency virus among medical residents in Mexico. Prev Med. 2001;32:424\u20138.","journal-title":"Prev Med"},{"key":"6795_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcv.2012.06.004","volume":"55","author":"A Vergara-Castaneda","year":"2012","unstructured":"Vergara-Castaneda A, Escobar-Gutierrez A, Ruiz-Tovar K, et al. Epidemiology of varicella in Mexico. J Clin Virol. 2012;55:51\u20137.","journal-title":"J Clin Virol"},{"key":"6795_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/archinte.1990.00390170032008","volume":"150","author":"JN Longfield","year":"1990","unstructured":"Longfield JN, Winn RE, Gibson RL, Juchau SV, Hoffman PV. Varicella outbreaks in Army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics. Arch Intern Med. 1990;150:970\u20133.","journal-title":"Arch Intern Med"},{"key":"6795_CR44","first-page":"237","volume":"113","author":"S Ruvinsky","year":"2015","unstructured":"Ruvinsky S, Taicz M, Perez MG, et al. Varicella at \u201ccasa Garrahan\u201d, 2008-2013: assessment of postexposure prophylaxis measures. Arch Argent Pediatr. 2015;113:237\u201343.","journal-title":"Arch Argent Pediatr"},{"key":"6795_CR45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.vaccine.2017.12.011","volume":"36","author":"AL Andrade","year":"2018","unstructured":"Andrade AL, da Silva Vieira MA, Minamisava R, et al. Single-dose varicella vaccine effectiveness in Brazil: A case-control study. Vaccine. 2018;36:479\u201383.","journal-title":"Vaccine."},{"key":"6795_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1590\/S0034-89102004000100006","volume":"38","author":"ESR Vico","year":"2004","unstructured":"Vico ESR, Laurenti R. Mortalidade de crian\u00e7as usu\u00e1rias de creches no Munic\u00edpio de S\u00e3o Paulo. Rev Saude Publica. 2004;38:38\u201344.","journal-title":"Rev Saude Publica"},{"key":"6795_CR47","first-page":"179","volume":"31","author":"C Canziani","year":"2015","unstructured":"Canziani C, Mart\u00ednez L, Amor\u00edn B, et al. Estudio cl\u00ednico epidemiol\u00f3gico de varicela en ni\u00f1os en el departamento de Paysand\u00fa: a\u00f1o 2013. Revista M\u00e9dica del Uruguay. 2015;31:179\u201387.","journal-title":"Revista M\u00e9dica del Uruguay"},{"key":"6795_CR48","first-page":"11","volume":"68","author":"ME Castillo Diaz","year":"2016","unstructured":"Castillo Diaz ME, Del Aguila O. Direct costs and clinical-epidemiological characteristics of hospitalized patients with chickenpox in 2013 at Instituto Nacional de Salud del Ni\u00f1o. Rev Peru Pediatr. 2016;68:11\u201322.","journal-title":"Rev Peru Pediatr"},{"key":"6795_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/S1726-46342013000100009","volume":"30","author":"E Miranda-Choque","year":"2013","unstructured":"Miranda-Choque E, Candela-Herrera J, D\u00edaz- Pera J, Farf\u00e1n-Ramos S, Mar\u00eda Mu\u00f1oz-Junes E, Rita Escalante-Santiva\u00f1ez I. Complicated chickenpox in a national pediatric Peruvian hospital, 2001-2011. Revista Peruana de Medicina Experimental y Salud P\u00fablica. 2013;30:45\u20138.","journal-title":"Revista Peruana de Medicina Experimental y Salud P\u00fablica"},{"key":"6795_CR50","first-page":"133","volume":"75","author":"DJ Quian","year":"2004","unstructured":"Quian DJ, R\u00fcttimann R, Matrai L. Prevalencia de anticuerpos contra varicela en una poblaci\u00f3n de Montevideo, Uruguay. Arch Pediatr Urug. 2004;75:133\u20138.","journal-title":"Arch Pediatr Urug."},{"key":"6795_CR51","first-page":"152","volume":"33","author":"SL Aranguren Segura","year":"2017","unstructured":"Aranguren Segura SL, Zuleta Due\u00f1as LP, Casta\u00f1eda-Porras O. Situaci\u00f3n epidemiol\u00f3gica de la Varicela, Casanare (Colombia), 2010-2014. Salud Uninorte. Barranquilla (Col). 2017;33:152\u201367.","journal-title":"Barranquilla (Col)"},{"key":"6795_CR52","unstructured":"Cashat M, Parellada CI, Monsanto H, et al. A review of the health & economic burden of varicella in Latin America and the Caribbean. Presented at: the ISPOR 6th Latin America conference; September 14\u201317, 2017; S\u00e3o Paulo, Brazil."},{"key":"6795_CR53","unstructured":"Pan American Health Organization, World health organization. Health in the Americas, 2012: Barbados https:\/\/www.paho.org\/salud-en-las-americas-2012\/index.php?option=com_content&view=article&id=23:barbados&Itemid=132&lang=en . Accessed 26 Nov 2018."},{"key":"6795_CR54","unstructured":"Pan American Health Organization, World Health Organization. Health in the Americas, 2012: Jamaica https:\/\/www.paho.org\/salud-en-las-americas-2012\/index.php?option=com_content&view=article&id=46:jamaica&Itemid=159&lang=en . Accessed 26 Nov 2018."},{"key":"6795_CR55","unstructured":"Ministerio de salud p\u00fablica y bienestar social (Paraguay). Lineamientos tecnicos y operativos para la vacunacion contra el virus de la varicela zoster. https:\/\/studylib.es\/doc\/6230741\/descargar-manual---ministerio-de-salud-p%C3%BAblica-y-bienesta... . Accessed 26 Nov 2018."},{"key":"6795_CR56","unstructured":"Ministerio de Salud (Argentina). Fundamentos de la introducci\u00f3n de la vacuna contra varicela. Al Calendario Nacional de Inmunizaciones 2015. http:\/\/www.msal.gob.ar\/images\/stories\/bes\/graficos\/0000000774cnt-2015-04_lineamientos-varicela.pdf . Accessed 26 Nov 2018."},{"key":"6795_CR57","unstructured":"Peru Ministerio de Salud. Casos de Varicela por DIRESAS notificantes y a\u00f1os 2008\u20132017. http:\/\/www.dge.gob.pe\/portal\/docs\/vigilancia\/sala\/2017\/SE15\/varicela.pdf . Accessed 26 Nov 2018."},{"key":"6795_CR58","unstructured":"Governo do Estado de S\u00e3o Palo, Secretaria de Estado da Sa\u00fade, CVE - Centro de Vigil\u00e2ncia Epidemiol\u00f3gica \u201cProf. Alexandre Vranjac\u201d. Dados estatisticos. http:\/\/www.saude.sp.gov.br\/cve-centro-de-vigilancia-epidemiologica-prof.-alexandre-vranjac\/areas-de-vigilancia\/doencas-de-transmissao-respiratoria\/agravos\/varicela\/dados-estatisticos . Accessed 26 Nov 2018."},{"key":"6795_CR59","doi-asserted-by":"crossref","unstructured":"Castillo M, Gutierrez R, Monsanto H, et al. Varicella-related healthcare resource utilization in Peru, 2011\u20132016. Presented at: the ISPOR 22nd annual international meeting; May 20\u201324, 2017; Boston, MA.","DOI":"10.1016\/j.jval.2017.08.2446"},{"key":"6795_CR60","first-page":"213","volume":"23","author":"ER Baldacci","year":"2002","unstructured":"Baldacci ER, Vico ESR. Mortalidade por varicela em crian\u00e7as atendidas em creche. Pediatria (S\u00e3o Paulo). 2002;23:213\u20136.","journal-title":"Pediatria (S\u00e3o Paulo)"},{"key":"6795_CR61","unstructured":"Vazquez M, PerezBolde-Villarreal C, Monsanto H, et al. The economic burden of varicella in Mexico. Presented at: SLIPE 2017 - XVII Congreso Latinoamericano de Infectolog\u00eda Pedi\u00e1trica; November 8-11, 2017; Cancun, Mexico."},{"key":"6795_CR62","unstructured":"Castillo M, Giglio N, Vazquez M, et al. Resource utilization among hospitalized pediatric varicella patients in Argentina, Peru, and Mexico. Presented at: SLIPE 2017 - XVII Congreso Latinoamericano de Infectolog\u00eda Pedi\u00e1trica; November 8\u201311, 2017; Cancun, Mexico."},{"key":"6795_CR63","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.vaccine.2008.07.021","volume":"26","author":"J Valentim","year":"2008","unstructured":"Valentim J, Sartori AM, de Soarez PC, Amaku M, Azevedo RS, Novaes HM. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil. Vaccine. 2008;26:6281\u201391.","journal-title":"Vaccine."},{"key":"6795_CR64","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.vaccine.2012.10.100","volume":"31","author":"A Paternina-Caicedo","year":"2013","unstructured":"Paternina-Caicedo A, De la Hoz-Restrepo F, Gamboa-Garay O, Castaneda-Orjuela C, Velandia-Gonzalez M, Alvis-Guzman N. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia. Vaccine. 2013;31:402\u20139.","journal-title":"Vaccine."},{"key":"6795_CR65","first-page":"A118","volume":"14","author":"F De la Hoz","year":"2011","unstructured":"De la Hoz F, Alvis N, Gamboa O, Casta\u00f1eda C, Paternina A. Cost-effectiveness analysis of the introduction of the varicella vaccine in Colombia. Value Health. 2011;14:A118.","journal-title":"Value Health"},{"key":"6795_CR66","unstructured":"Graham J, Talbird SE, Monsanto H, et al. Budget impact of a one-dose varicella vaccination program using outputs of a dynamic transmission model: Mexican national perspective. Presented at: SLIPE 2017 - XVII Congreso Latinoamericano de Infectolog\u00eda Pedi\u00e1trica; November 8\u201311, 2017; Cancun, Mexico."},{"key":"6795_CR67","unstructured":"Blas M, Gutierrez R, Petrozzi V, et al. The cost effectiveness of varicella vaccination in Peru. Presented at: the ISPOR 6th Latin America conference; September 14\u201317, 2017; S\u00e3o Paulo, Brazil."},{"key":"6795_CR68","unstructured":"Torres JP, Massoc Pacheco MA, Kyle J, et al. Is it time for universal varicella vaccination in Chile? A health economic analysis. Presented at: the 18th International Congress on Infectious Diseases; March 1\u20134, 2018; Buenos Aires, Argentina."},{"key":"6795_CR69","doi-asserted-by":"crossref","unstructured":"Giglio N, Carrega P, Eugenia M, et al. An economic evaluation of varicella vaccination in Argentina. Presented at: the 18th International Congress on Infectious Diseases; March 1\u20134, 2018; Buenos Aires, Argentina.","DOI":"10.1016\/j.ijid.2018.04.3453"},{"key":"6795_CR70","doi-asserted-by":"crossref","unstructured":"Perez Bolde C, Monsanto H, Pillsbury M, et al. The cost effectiveness of strategies to vaccinate against varicella in Mexico. Presented at: the ISPOR 22nd annual international meeting; may 20\u201324, 2017; Boston, MA.","DOI":"10.1016\/j.jval.2017.08.3011"},{"key":"6795_CR71","unstructured":"Pan American Health Organization, World Health Organization. Pan American Journal of Public Health. Special issue on immunization in the Americas. http:\/\/www.paho.org\/journal\/index.php?option=com_content&view=article&id=231:recently-published-articles-pai-december-2017&Itemid=861\/ . November 26, 2018."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6795-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T19:21:56Z","timestamp":1721244116000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6795-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6795"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6795-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Luiza Helena Falleiros Arlant received a grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, for activities related to the current study. Luiza Helena Falleiros Arlant also receives speaker\u2019s honoraria from Merck & Co., Inc., Pfizer and Sanofi Pasteur and fees from Pharmaceutical Industries as a member of Advisory Boards.Miguel Cashat, Cintia Irene Parellada, and Lara J. Wolfson are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.The other authors have not reported completing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"528"}}